22157.jpg
Global Antisense & RNAi Therapeutics Market Report 2021: Market is Expected to Reach $1.79 Billion in 2025 at a CAGR of 11% - Forecast to 2030
June 17, 2021 07:03 ET | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Cytogenetics Market (2020 to 2030) - Key Technologies, Markets & Companies
April 23, 2021 05:58 ET | Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
22157.jpg
Global RNAi Technologies, Markets & Companies Report 2020-2028: Gene Editing with for COVID-19 by RNA-Targeting CRISPR Systems & mRNA Vaccines for COVID-19
April 20, 2021 06:23 ET | Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The markets for RNAi...
Emergen logo.png
RNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 | Increasing Demand for Precision Medicines And Growing Investment are Major Factors Fueling Industry Growth, says Emergen Research
April 12, 2021 17:00 ET | Emergen Research
VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) -- The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 and register a steady CAGR during the...
22157.jpg
Global Antisense & RNAi Therapeutics Market (2020 to 2030) - Opportunities and Strategies
April 07, 2021 05:23 ET | Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
22157.jpg
Outlook on the Antisense Oligonucleotide Therapeutics Global Market to 2030 - Featuring Biogen, Bio-Path Holdings and Sarepta Therapeutics Among Others
April 01, 2021 05:48 ET | Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics Market by Target Indication, Type of Therapy, Type of Molecule Type of Generation and Key Geographies: Industry...
22157.jpg
Global Antisense and RNAi Therapeutics Market Report 2021: Market to Reach $1.9 Billion by 2027 - Antisense RNA Segment is Projected to Account for $974.2 Million
March 30, 2021 07:38 ET | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Antisense and RNAi Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
Global RNA Interference Drug Delivery Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
December 21, 2020 06:53 ET | Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
22157.jpg
Global RNAi Technologies, Markets & Companies Report 2020 with Profiles of 167 Companies Along with 229 Collaborations
September 21, 2020 04:13 ET | Research and Markets
Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The report...
22157.jpg
Cytogenetics Market, 2029
September 10, 2020 10:24 ET | Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...